Back to top
more

CONMED (CNMD)

(Delayed Data from NYSE)

$66.59 USD

66.59
461,560

+0.03 (0.05%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $66.56 -0.03 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (171 out of 252)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

IDEXX (IDXX) Earnings Beat Estimates in Q1, '21 View Up

IDEXX (IDXX) registers strong contribution from its CAG business in the first quarter despite pandemic-induced challenges.

Orthofix's (OFIX) Q1 Earnings Top Estimates, 2021 View Up

Strong sales of Orthofix's (OFIX) M6-C artificial disc and FITBONE lengthening nail drive its Q1 top line.

CONMED (CNMD) Surges 4.2%: Is This an Indication of Further Gains?

CONMED (CNMD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

CONMED (CNMD) Earnings and Revenue Surpass Estimates in Q1

CONMED (CNMD) witnesses growth in revenues in both its segments during Q1.

Conmed (CNMD) Tops Q1 Earnings and Revenue Estimates

Conmed (CNMD) delivered earnings and revenue surprises of 46.51% and 7.01%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Conmed (CNMD) to Report a Decline in Earnings: What to Look Out for

Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain CONMED (CNMD) Stock for Now

Investor optimism is high on CONMED (CNMD) stock, courtesy of its solid prospects.

CONMED (CNMD) Q4 Earnings Beat Estimates, Revenues Miss

Despite weak segmental performance in fourth quarter, CONMED (CNMD) showed strength and resilience in amid a tough operating environment.

Conmed (CNMD) Q4 Earnings Surpass Estimates

Conmed (CNMD) delivered earnings and revenue surprises of 7.69% and -3.91%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

MCK or CNMD: Which Is the Better Value Stock Right Now?

MCK vs. CNMD: Which Stock Is the Better Value Option?

LH or CNMD: Which Is the Better Value Stock Right Now?

LH vs. CNMD: Which Stock Is the Better Value Option?

Here's Why You Should Hold on to CONMED (CNMD) Stock for Now

Investor confidence is high on CONMED (CNMD) stock, thanks to solid prospects.

LH or CNMD: Which Is the Better Value Stock Right Now?

LH vs. CNMD: Which Stock Is the Better Value Option?

LH vs. CNMD: Which Stock Should Value Investors Buy Now?

LH vs. CNMD: Which Stock Is the Better Value Option?

CONMED (CNMD) Earnings and Revenues Surpass Estimates in Q3

CONMED's (CNMD) General Surgery unit witnessed revenue growth in Q3

Conmed (CNMD) Q3 Earnings and Revenues Top Estimates

Conmed (CNMD) delivered earnings and revenue surprises of 252.00% and 16.07%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Conmed (CNMD) to Report a Decline in Earnings: What to Look Out for

Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Avoid Betting on Integer Holdings Now

Stiff competition in the MedTech space and weak segmental and operational performance weighs on Integer Holdings (ITGR).

Cerner Inks Deal to Simplify Advance Care Planning Procedure

Cerner's (CERN) partners with Vynca to simplify advance care planning process, thereby enabling patients and clinicians to discuss and make critical end-of-life decisions.

Here's Why You Should Hold on to CONMED (CNMD) Stock for Now

Investor confidence is high on CONMED (CNMD) stock, thanks to solid prospects.

PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?

PDCO vs. CNMD: Which Stock Is the Better Value Option?

CONMED (CNMD) Q2 Loss Narrower Than Expected, Revenues Top

CONMED's (CNMD) core units - General Surgery and Orthopedic Surgery - witnessed revenue decline in Q2.

Conmed (CNMD) Reports Q2 Loss, Tops Revenue Estimates

Conmed (CNMD) delivered earnings and revenue surprises of 93.14% and 22.20%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Should You Buy CONMED (CNMD) Ahead of Earnings?

CONMED (CNMD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Conmed (CNMD) is Poised to Beat Earnings Estimates Again

Conmed (CNMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.